PDS Biotechnology's total assets for Q1 2025 were $47.03B, an increase of 103581.51% from the previous quarter. PDSB total liabilities were $24.67B for the fiscal quarter, a 93496.84% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.